Form 8-K: Current report, items 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.07, and 9.01

Anchiano Therapeutics Ltd. filed this Form 8-K on 3/17/2021

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

8-K (LINK) PDF  


Description Link to document Type
FORM 8-K tm219877d1_8k.htm 8-K
EXHIBIT 3.1 tm219877d1_ex3-1.htm EX-3.1
EXHIBIT 10.1 tm219877d1_ex10-1.htm EX-10.1
EXHIBIT 10.2 tm219877d1_ex10-2.htm EX-10.2
EXHIBIT 10.3 tm219877d1_ex10-3.htm EX-10.3
EXHIBIT 10.4 tm219877d1_ex10-4.htm EX-10.4
EXHIBIT 99.1 tm219877d1_ex99-1.htm EX-99.1
EXHIBIT 99.2 tm219877d1_ex99-2.htm EX-99.2
GRAPHIC tm219877d1_ex99-1img01.jpg GRAPHIC
GRAPHIC tm219877d1_ex99-1img02.jpg GRAPHIC
GRAPHIC tm219877d1_ex99-2img01.jpg GRAPHIC
Complete submission text file 0001104659-21-037294.txt